Birth weight corrected for gestational age is related to the incidence of Down's syndrome pregnancies

Twin Research

Volumn 4, Issue 5, 2001, Pages 318-320

  Van Montfrans, Joris M ^a   Bakker, Petra S M ^a   Rekers Mombarg, Lyset T M ^a   Van Weissenbruch, Mirjam M ^a   Lambalk, Cornelis B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; OOCYTE DEVELOPMENT; OVARY FOLLICLE; OVARY FOLLICLE ATRESIA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SMALL FOR DATE INFANT;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; PREGNANCY;

EID: 0035714192     PISSN: 13690523     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.4.5.318     Document Type: Article

References (11)

1. The long-term outcome of retarded fetal growth
2. Organization of the ovarian follicle and events in its biology: Oogenesis, ovulation or atresia
3. Fetal growth retardation as a cause of impaired ovarian development
4. Parental age-related aneuploidy in human germ cells and offspring: A story of past and present
5. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause
6. Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome
7. Impaired fetal growth and atherosclerosis of carotid and peripheral arteries
8. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension
9. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy
10. Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
11. Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome